HeartWare to float new shares
Thursday, 05 June, 2008
HeartWare (ASX: HTW) will hold an extraordinary general meeting next month to receive shareholder permission to float up to 70 million new shares.
The shares will be offered privately to professional investors in Australia and the US, and will be sold at $0.50 cents a share.
The purpose of the listing is to raise $30 million in capital. HeartWare, which manufactures miniature medical devices, will offer a share purchase plan to allow current stockholders the opportunity to purchase the new shares at the same price as that offered to the private investors.
Researchers genetically engineer snake antivenom
An international team of researchers has used genetic engineering to create so-called...
Common medications linked to adverse breast cancer outcomes
An international study has found concerning evidence about the impact of a range of common...
Saliva-based biosensor could improve heart failure detection
Scientists have created a biosensor that can rapidly detect the heart failure biomarker S100A7 in...
